Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor as a support for chemotherapy for gestational trophoblastic neoplasia: a propensity score matching analysis

PEG-rhG-CSF has good efficacy and safety in preventing hematological toxicity in GTN patients after chemotherapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-09-22
DOI
https://doi.org/10.3389/fonc.2025.1590189
Primary Topic
Gestational Trophoblastic Disease Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor as a support for chemotherapy for gestational trophoblastic neoplasia: a propensity score matching analysis

Haiqiong Han, Zhiguo Li, Lijuan Yan, Hongwei Zhao et al.
Frontiers in Oncology
Gestational Trophoblastic Disease Studies
article

Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor as a support for chemotherapy for gestational trophoblastic neoplasia: a propensity score matching analysis

Haiqiong Han, Zhiguo Li, Lijuan Yan, Hongwei Zhao, Xin Zhao
article en

Abstract

PEG-rhG-CSF has good efficacy and safety in preventing hematological toxicity in GTN patients after chemotherapy.

Frontiers in OncologyVol. 15
Shanxi Provincial Cancer Hospital (CN)
Openalex Percentile: Top 65%
Gestational Trophoblastic Disease Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.